$20.12
0.261.31%
Last update: Nov 5, 2:22 AM
Vor Biopharma Inc
VORNASDAQ
The average analyst price target for Vor Biopharma is $61.67, 208.3% above the current price. Of 13 analysts, 11 rate it Buy and 2 Hold. Targets range from $8 to $160. The latest change came on Oct 21, 2026, when William Blair initiated coverage of Vor Biopharma with an Outperform rating.
Price Target Range — 11 Quarters
Analyst Consensus — 13 Analysts
Rating Trend — Last 9 Months
